DavidSeymourEttingerMD
Oncology • Lutherville, MDProfessor of Oncology, Professor of Gynecology and Obstetrics, Professor of Medicine, Professor of Otolaryngology-Head and Neck Surgery, Professor of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine
Dr. Ettinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10755 Falls Rd
Lutherville, MD 21093Phone+1 410-583-2970
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1973 - 1975
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1968 - 1971
Albany Medical CenterInternship, Transitional Year, 1967 - 1968
University of Louisville School of MedicineClass of 1967
Certifications & Licensure
MD State Medical License 1974 - 2024
DC State Medical License 2013 - 2020
MN State Medical License 1968 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Start of enrollment: 1994 Mar 01
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma Start of enrollment: 1998 Oct 13
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall Start of enrollment: 2004 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- 616 citationsNon-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman
Journal of the National Comprehensive Cancer Network. 2022-05-01 - 6 citationsSex-specific differences in immunogenomic features of response to immune checkpoint blockade.Susan C Scott, Xiaoshan M Shao, Noushin Niknafs, Archana Balan, Gavin Pereira
Frontiers in Oncology. 2022-01-01 - 148 citationsAntiemesis, version 2.2017 featured updates to the NCCN guidelinesMichael Berger, David S. Ettinger, Jonathan Aston, Sally Y. Barbour, Jason J Bergsbaken
Journal of the National Comprehensive Cancer Network. 2017-07-01
Press Mentions
PD-L1 Inhibitor Avelumab May Improve Survival in Metastatic Urothelial CarcinomaOctober 7th, 2015- Dr David Ettinger Discusses the Road Ahead for Immunotherapy in NSCLCOctober 6th, 2015
Grant Support
- Eastern Cooperative Oncology GroupNational Cancer Institute1985–1992
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-ettinger
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
